Rubric Capital Management (New York)’s Werewolf Therapeutics HOWL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-1,333,893
| Closed | -$1.3M | – | 66 |
|
2025
Q1 | $1.3M | Hold |
1,333,893
| – | – | 0.02% | 64 |
|
2024
Q4 | $1.97M | Hold |
1,333,893
| – | – | 0.03% | 65 |
|
2024
Q3 | $2.83M | Hold |
1,333,893
| – | – | 0.05% | 59 |
|
2024
Q2 | $3.25M | Sell |
1,333,893
-287,141
| -18% | -$701K | 0.09% | 63 |
|
2024
Q1 | $10.5M | Sell |
1,621,034
-314,323
| -16% | -$2.04M | 0.31% | 56 |
|
2023
Q4 | $7.47M | Hold |
1,935,357
| – | – | 0.16% | 48 |
|
2023
Q3 | $4.14M | Hold |
1,935,357
| – | – | 0.16% | 54 |
|
2023
Q2 | $5.9M | Hold |
1,935,357
| – | – | 0.25% | 53 |
|
2023
Q1 | $5.03M | Buy |
1,935,357
+99,970
| +5% | +$260K | 0.13% | 61 |
|
2022
Q4 | $3.76M | Buy |
1,835,387
+868,508
| +90% | +$1.78M | 0.16% | 78 |
|
2022
Q3 | $4.36M | Buy |
966,879
+761,883
| +372% | +$3.44M | 0.22% | 64 |
|
2022
Q2 | $838K | Buy |
+204,996
| New | +$838K | 0.04% | 87 |
|